| PERIOD ENDING | 25-Oct-09 | 26-Jul-09 | 26-Apr-09 | 25-Jan-09 | | Total Revenue | 903,206 | 776,520 | 664,231 | 481,140 | | Cost of Revenue | 511,423 | 619,797 | 474,535 | 339,474 | | | Gross Profit | 391,783 | 156,723 | 189,696 | 141,666 | | | Operating Expenses | | Research Development | 197,948 | 192,855 | 301,797 | 211,779 | | Selling General and Administrative | 85,990 | 73,975 | 118,864 | 86,440 | | Non Recurring |
-
|
-
|
-
| 18,530 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 107,845 | (110,107) | (230,965) | (175,083) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,362 | 3,006 | 6,144 | 5,114 | | Earnings Before Interest And Taxes | 110,207 | (107,101) | (224,821) | (169,969) | | Interest Expense |
-
|
-
|
-
| 406 | | Income Before Tax | 110,207 | (107,101) | (224,821) | (170,375) | | Income Tax Expense | 2,630 | (1,799) | (23,483) | (22,710) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 107,577 | (105,302) | (201,338) | (147,665) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 107,577 | (105,302) | (201,338) | (147,665) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $107,577 | ($105,302) | ($201,338) | ($147,665) |
|
0.60% Nasdaq 
Income Statement
